داروسازی زاگرس فارمد پارس
ددام | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 11,720 2.98
Close Price: 11,720
Cash Flow
AGM
Interim
2026/06/17 Fiscal Year 2026/03/2012 Month / Audited | 2026/05/18 Fiscal Year 2026/03/2012 Month | ||
|---|---|---|---|
Cash Generated from Operations | 1.973 Trillion | 1.876 Trillion | |
Income Taxes Paid | -401.361 Billion | -401.361 Billion | |
Net Cash Flow from Operating Activities | 1.571 Trillion | 1.475 Trillion | |
Purchases of Property, Plant and Equipment | -10.722 Billion | -10.722 Billion | |
Purchases of Intangible Assets | -8.591 Billion | -8.591 Billion | |
Dividends Received | 1.828 Billion | 1.828 Billion | |
Cash Received from Income on Other Investments | 81 Million | 81 Million | |
Net Cash Flow from Investing Activities | -17.404 Billion | -17.404 Billion | |
Net Cash Flow before Financing Activities | 1.554 Trillion | 1.458 Trillion | |
Proceeds from Sale of Treasury Shares | 133.524 Billion | - | |
Purchases of Treasury Shares | -127.501 Billion | - | |
Cash Received from Borrowings | 2.429 Trillion | 2.429 Trillion | |
Repayments of Borrowings (Principal) | -2.857 Trillion | -2.857 Trillion | |
Interest Paid on Borrowings | -413.369 Billion | -413.369 Billion | |
Dividends Paid | -920.763 Billion | -818.234 Billion | |
Net Cash Flow from Financing Activities | -1.756 Trillion | -1.659 Trillion | |
Net Increase (Decrease) in Cash | -201.571 Billion | -201.571 Billion | |
Cash at Beginning of Period | 240.568 Billion | 240.568 Billion | |
Effect of Exchange Rate Changes | 3.561 Billion | 3.561 Billion | |
Cash at End of Period | 244.129 Billion | 244.129 Billion | |
Non-Cash Transactions | 672.5 Billion | - |